Dear pharma & life sciences colleagues,
It was a pleasure to welcome you to our webinar: PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA.
Attached below you can download the presentation.
Continue reading PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNAAs the COVID-19 situation develops, tax and regulatory specialists within the pharmaceutical & life sciences industry are increasingly facing complex challenges. Efficient and pragmatic solutions have to be realised, with fewer resources, in line with the changing local legislation.
The exchange of information is the best practice in this industry to support and inspire you in your daily business.
Continue reading PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA – Thursday 28. May 2020, 10:30 CESTDear All
I would like to invite you to our next webinar “PwC webinar – “Sourcing and manufacturing without side effects!” which will be held on 31 March 2020 from 3:00 pm to 4:00 pm and on 1 April 2020 from 9.00 am to 10.00 am.
We will also include some ITX Updates related on COVID-19.
Continue reading PwC webinar – “Sourcing and manufacturing without side effects!” / COVID-19 ITX UpdateDear All
I would like to invite you to our next webinar “Pharma & VAT Quick Fixes – Exploring the Right Formula which will be held on 8 November 2019 from 9:00am to 10:00am and from 3.00pm to 4.00pm.
Continue reading Webinar: Pharma & VAT Quick Fixes – Exploring the Right FormulaDear all,
Happy to invite you to have a look to our latest PwC Webinar on precision medicines and the respective hot topics in the VAT field for the US, Europe, Switzerland and Asia. Continue reading Webinar on indirect tax issues in Precision Medicine
I am pleased to invite you to our Webinar on Precision Medicine
and Accurate Indirect Tax
During this digital presentation our panel of experts will give you an overview of possible indirect tax implications within the pharma sector. This panel consists of many tax specialists of the pharmaceutical sector and PwC’s international indirect tax experts. Experts, who are dedicated to the pharmaceutical industry.
I will use my time slot to discuss the implications for Switzerland including which countries will be covered.
You will have the opportunity to exchange your experiences and views on the issue with other international leaders.
Learn the latest news at our next international webinar
“ITX Pharma & Life Sciences Virtual Round Table” related to the ECJ Boehringer Ingelheim case.
I am looking forward to sharing this event with you.
In December the United States enacted the most comprehensive tax reform in more than 30 years. For the Pharmaceutical and Life Sciences sector, the changes won’t just impact US based businesses but companies based outside the US who trade there.
Join PwC’s tax and industry specialists in a live webinar from New York.
Our specialists will be available to take questions following the presentation.
15 May 2018 | 14:00 BST (London) / 15:00 CEST (Paris) / 9:00AM EST (New York)
Presenter: Kathy Michael, PwC’s US Pharmaceutical & Life Sciences Tax Sector Leader
Access instructions: Click here to register and access the webinar.
If you cannot view the webinar on your PC, you may dial in to the audio-only phone line:
+1 651 291 3245 / Passcode: 448492 #
If you have any questions please don’t hesitate to contact me.
